Commitment COM-241
Post-approval commitment for FDA-2024-0041. Category: Manufacturing. Priority: low.
Commitment ID
COM-241
Application
Authority
Food and Drug Administration
Category
Manufacturing
Priority
low
Status
In Progress
Due Date
2025-02-14
Completed At
—
Owner
Sarah Chen
Created
2023-07-29
Description
Provide confirmatory bioequivalence study for 200 mg strength
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.